Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SAUL CENTERS, INC.BFS · Entity 4877 | Director · SVP-Res. Design/Mrkt Research | May 17, 2026 | May 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SAUL CENTERS, INC.
Report date May 17, 2026 · Filed May 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,814.068 |
Ending reported balance
After 2026-05-17 transaction · row 3
2 source rows · reconciled sequenceRow 2 · 2026-05-17 · Tax withholding · Disposed 35 · Balance 4,804.068 Row 3 · 2026-05-17 · Grant · Acquired 10 · Balance 4,814.068 F1: Shares acquired in an exempt transaction as dividend equivalents on filers restricted stock award, which vested on May 17, 2026. |
| Common StockSEC Table I · non-derivative | IndirectSpouse-401K | 249.952 |
Reported balance
Holding disclosure · report date 2026-05-17 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 249.952 |
| Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $55.71 · Expires 2029-05-03 | Direct | 5,000 |
Reported balance
Holding disclosure · report date 2026-05-17 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 5,000 F2: The options vest 25% per year over four years from the date of grant. |
| Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $50.00 · Expires 2030-04-24 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2026-05-17 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 10,000 F2: The options vest 25% per year over four years from the date of grant. |
| Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $43.89 · Expires 2031-05-07 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2026-05-17 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 10,000 F2: The options vest 25% per year over four years from the date of grant. |
| Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $47.90 · Expires 2032-05-13 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2026-05-17 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 10,000 F2: The options vest 25% per year over four years from the date of grant. |
| Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $33.79 · Expires 2033-05-12 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2026-05-17 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 10,000 F2: The options vest 25% per year over four years from the date of grant. |
| Director Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $55.71 · Expires 2029-05-03 | Direct | 2,500 |
Reported balance
Holding disclosure · report date 2026-05-17 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 2,500 |
| Director Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $50.00 · Expires 2030-04-24 | Direct | 2,500 |
Reported balance
Holding disclosure · report date 2026-05-17 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 2,500 |
| Director Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $43.89 · Expires 2031-05-07 | Direct | 2,500 |
Reported balance
Holding disclosure · report date 2026-05-17 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 2,500 |
| Director Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $47.90 · Expires 2032-05-13 | Direct | 2,500 |
Reported balance
Holding disclosure · report date 2026-05-17 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 2,500 |
| Director Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $33.79 · Expires 2033-05-12 | Direct | 2,500 |
Reported balance
Holding disclosure · report date 2026-05-17 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 2,500 |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 4,243.322 |
Reported balance
Holding disclosure · report date 2026-05-17 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 4,243.322 F3: New phantom shares are issuable pursuant to the Issuers Deferred Compensation Plan for Directors, as amended and restated effective May 17, 2024 (the Deferred Compensation Plan), under its 2024 Stock Incentive Plan. Phantom shares issued prior to May 17, 2024, continue to be subject to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan. F4: The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement. |
| Performance SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2029-05-17 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-05-17 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 300 |
| Performance SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2030-05-09 | Direct | 400 |
Reported balance
Holding disclosure · report date 2026-05-17 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 400 |
| Performance SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2031-05-08 | Direct | 500 |
Reported balance
Holding disclosure · report date 2026-05-17 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 500 |
Filing footnotes · ownership attribution and instrument terms
F1: Shares acquired in an exempt transaction as dividend equivalents on filers restricted stock award, which vested on May 17, 2026.
F2: The options vest 25% per year over four years from the date of grant.
F3: New phantom shares are issuable pursuant to the Issuers Deferred Compensation Plan for Directors, as amended and restated effective May 17, 2024 (the Deferred Compensation Plan), under its 2024 Stock Incentive Plan. Phantom shares issued prior to May 17, 2024, continue to be subject to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan.
F4: The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 23, 2020 Filed Mar 24, 2020 16:25 UTC | SAUL CENTERS, INC. BFS · Entity 4877 | PurchaseCommon Shares | 200 | $25.16 | $5,032.00 |
DisclosureSEC source: 0000907254-20-000021 · wf-form4_158506713762981.xml · nonDerivative · entry 4 Laycock Willoughby B. · CIK 0001771496 · Director · Senior V.P.-Residential 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 245 F5 · ownership.nature: Shares owned directly by the reporting person's spouse. The reporting person disclaims beneficial ownership of these shares. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:53 UTC | SAUL CENTERS, INC. BFS · Entity 4877 | GrantPhantom Stock · Derivative | 120.411 | $51.49 Strike: $51.49 | $6,199.96 |
DisclosureSEC source: 0000907254-20-000002 · wf-form4_157834757353018.xml · derivative · entry 5 Laycock Willoughby B. · CIK 0001771496 · Director · Senior V.P.-Residential 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 513.661 Underlying: Common Stock · 120.411 shares Expires not disclosed F6 · derivative.exercise_date: The conversion of phantom stock into shares of the issuer's common stock is governed pursuant to terms of the issuer's Deferred Compensation Plan under its 2004 Stock Plan, as amended, and the reporting person's Deferred Fee Agreement. F6 · derivative.expiration_date: The conversion of phantom stock into shares of the issuer's common stock is governed pursuant to terms of the issuer's Deferred Compensation Plan under its 2004 Stock Plan, as amended, and the reporting person's Deferred Fee Agreement. F7 · balance_after: Includes 3.905 shares ($52.8407/share) awarded October 31, 2019 as dividend reinvestments on shares of phantom stock held by the reporting person pursuant to the issuer's Deferred Compensation Plan under its 2004 Stock Plan and shares of phantom stock issued under the issuer's Deferred Compensation Stock Plan for Directors. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 16:02 UTC | SAUL CENTERS, INC. BFS · Entity 4877 | GrantPhantom Stock · Derivative | 116.323 | $53.30 Strike: $53.30 | $6,200.02 |
DisclosureSEC source: 0000907254-19-000076 · wf-form4_157011850029880.xml · derivative · entry 5 Laycock Willoughby B. · CIK 0001771496 · Director · Senior V.P.-Residential 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366.831 Underlying: Common Stock · 116.323 shares Expires not disclosed F6 · derivative.exercise_date: The conversion of phantom stock into shares of the issuer's common stock is governed pursuant to terms of the issuer's Deferred Compensation Plan under its 2004 Stock Plan, as amended, and the reporting person's Deferred Fee Agreement. F6 · derivative.expiration_date: The conversion of phantom stock into shares of the issuer's common stock is governed pursuant to terms of the issuer's Deferred Compensation Plan under its 2004 Stock Plan, as amended, and the reporting person's Deferred Fee Agreement. F7 · balance_after: Includes 2.450 shares ($53.6555/share) awarded July 31, 2019 as dividend reinvestments on shares of phantom stock held by the reporting person pursuant to the issuer's Deferred Compensation Plan under its 2004 Stock Plan and shares of phantom stock issued under the issuer's Deferred Compensation Stock Plan for Directors. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 18:22 UTC | SAUL CENTERS, INC. BFS · Entity 4877 | GrantPhantom Stock · Derivative | 133.84 | $55.29 Strike: $55.29 | $7,400.01 |
DisclosureSEC source: 0000907254-19-000061 · wf-form4_156209170850585.xml · derivative · entry 5 Laycock Willoughby B. · CIK 0001771496 · Director · Senior V.P.-Residential 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248.058 Underlying: Common Stock · 133.84 shares Expires not disclosed F4 · derivative.exercise_date: The conversion of phantom stock into shares of the issuer's common stock is governed pursuant to terms of the issuer's Deferred Compensation Plan under its 2004 Stock Plan, as amended, and the reporting person's Deferred Fee Agreement. F4 · derivative.expiration_date: The conversion of phantom stock into shares of the issuer's common stock is governed pursuant to terms of the issuer's Deferred Compensation Plan under its 2004 Stock Plan, as amended, and the reporting person's Deferred Fee Agreement. Read SEC document |
| May 03, 2019 Filed May 7, 2019 17:11 UTC | SAUL CENTERS, INC. BFS · Entity 4877 | GrantDirector Stock Option · Derivative | 2,500 | $55.71 Strike: $55.71 | $139,275.00 |
DisclosureSEC source: 0000907254-19-000033 · wf-form4_155724906943924.xml · derivative · entry 7 Laycock Willoughby B. · CIK 0001771496 · Director · Senior V.P.-Residential 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2029-05-03 F8 · derivative.exercise_date: The options vest 25% per year over four years from the date of grant. Read SEC document |
| May 03, 2019 Filed May 7, 2019 17:11 UTC | SAUL CENTERS, INC. BFS · Entity 4877 | GrantEmployee Stock Option · Derivative | 5,000 | $55.71 Strike: $55.71 | $278,550.00 |
DisclosureSEC source: 0000907254-19-000033 · wf-form4_155724906943924.xml · derivative · entry 6 Laycock Willoughby B. · CIK 0001771496 · Director · Senior V.P.-Residential 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-05-03 Read SEC document |
| May 03, 2019 Filed May 7, 2019 17:11 UTC | SAUL CENTERS, INC. BFS · Entity 4877 | GrantCommon Shares | 200 | $55.71 | $11,142.00 |
DisclosureSEC source: 0000907254-19-000033 · wf-form4_155724906943924.xml · nonDerivative · entry 4 Laycock Willoughby B. · CIK 0001771496 · Director · Senior V.P.-Residential 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 18:49 UTC | SAUL CENTERS, INC. BFS · Entity 4877 | GrantPhantom Stock · Derivative | 95.988 | $52.09 Strike: $52.09 | $5,000.01 |
DisclosureSEC source: 0000907254-19-000014 · wf-form4_155423096284472.xml · derivative · entry 5 Laycock Willoughby B. · CIK 0001771496 · Director · VP-Residential Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95.988 Underlying: Common Stock · 95.988 shares Expires not disclosed F1 · derivative.exercise_date: The conversion of phantom stock into shares of the issuer's common stock is governed pursuant to terms of the issuer's Deferred Compensation Plan under its 2004 Stock Plan, as amended, and the reporting person's Deferred Fee Agreement. F1 · derivative.expiration_date: The conversion of phantom stock into shares of the issuer's common stock is governed pursuant to terms of the issuer's Deferred Compensation Plan under its 2004 Stock Plan, as amended, and the reporting person's Deferred Fee Agreement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.